Diabetes type1
26
7
7
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
1 terminated out of 26 trials
92.3%
+5.8% vs benchmark
8%
2 trials in Phase 3/4
33%
4 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (26)
Host-microbiota-environment Interactions
Dual Hormone Closed Loop in Type 1 Diabetes
Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
Exploration of Health Literacy in Diabetes in Reunion Island and France
Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1
Evaluation of the MiniMed 780 System in Paediatric Subjects
cePolyTregs in Islet Transplantation
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
Impact of Gravity on Cardiac Hemodynamics
Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes
Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes
Role of Adrenaline in in the Inflammatory Response in Diabetes
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System
T1D Closed-loop and Physical Activity
Simple Initiation of Advanced Hybrid Closed Loop System